These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Crystal structure of the BARD1 BRCT domains. Birrane G; Varma AK; Soni A; Ladias JA Biochemistry; 2007 Jul; 46(26):7706-12. PubMed ID: 17550235 [TBL] [Abstract][Full Text] [Related]
24. The effects of BRCA1 missense variants V1804D and M1628T on transcriptional activity. Ostrow KL; McGuire V; Whittemore AS; DiCioccio RA Cancer Genet Cytogenet; 2004 Sep; 153(2):177-80. PubMed ID: 15350310 [TBL] [Abstract][Full Text] [Related]
25. Analysis of missense variation in human BRCA1 in the context of interspecific sequence variation. Abkevich V; Zharkikh A; Deffenbaugh AM; Frank D; Chen Y; Shattuck D; Skolnick MH; Gutin A; Tavtigian SV J Med Genet; 2004 Jul; 41(7):492-507. PubMed ID: 15235020 [TBL] [Abstract][Full Text] [Related]
26. BRCA1 DNA-binding activity is stimulated by BARD1. Simons AM; Horwitz AA; Starita LM; Griffin K; Williams RS; Glover JN; Parvin JD Cancer Res; 2006 Feb; 66(4):2012-8. PubMed ID: 16489000 [TBL] [Abstract][Full Text] [Related]
27. BRCA1 as tumor suppressor: lord without its RING? Elia AE; Elledge SJ Breast Cancer Res; 2012 Apr; 14(2):306. PubMed ID: 22494569 [TBL] [Abstract][Full Text] [Related]
28. Predicting pathogenicity of missense variants with weakly supervised regression. Cao Y; Sun Y; Karimi M; Chen H; Moronfoye O; Shen Y Hum Mutat; 2019 Sep; 40(9):1579-1592. PubMed ID: 31144781 [TBL] [Abstract][Full Text] [Related]
29. A yeast recombination assay to characterize human BRCA1 missense variants of unknown pathological significance. Caligo MA; Bonatti F; Guidugli L; Aretini P; Galli A Hum Mutat; 2009 Jan; 30(1):123-33. PubMed ID: 18680205 [TBL] [Abstract][Full Text] [Related]
30. Functional and mutational landscapes of BRCA1 for homology-directed repair and therapy resistance. Anantha RW; Simhadri S; Foo TK; Miao S; Liu J; Shen Z; Ganesan S; Xia B Elife; 2017 Apr; 6():. PubMed ID: 28398198 [TBL] [Abstract][Full Text] [Related]
31. Mapping the functional domains of BRCA1. Interaction of the ring finger domains of BRCA1 and BARD1. Meza JE; Brzovic PS; King MC; Klevit RE J Biol Chem; 1999 Feb; 274(9):5659-65. PubMed ID: 10026184 [TBL] [Abstract][Full Text] [Related]
32. Molecular Analysis of BRCA1 in Human Breast Cancer Cells Under Oxidative Stress. Gilmore BL; Liang Y; Winton CE; Patel K; Karageorge V; Varano AC; Dearnaley W; Sheng Z; Kelly DF Sci Rep; 2017 Mar; 7():43435. PubMed ID: 28262780 [TBL] [Abstract][Full Text] [Related]
33. A new bioinformatics tool to help assess the significance of BRCA1 variants. Cusin I; Teixeira D; Zahn-Zabal M; Rech de Laval V; Gleizes A; Viassolo V; Chappuis PO; Hutter P; Bairoch A; Gaudet P Hum Genomics; 2018 Jul; 12(1):36. PubMed ID: 29996917 [TBL] [Abstract][Full Text] [Related]
35. "DNA Binding Region" of BRCA1 Affects Genetic Stability through modulating the Intra-S-Phase Checkpoint. Masuda T; Xu X; Dimitriadis EK; Lahusen T; Deng CX Int J Biol Sci; 2016; 12(2):133-43. PubMed ID: 26884712 [TBL] [Abstract][Full Text] [Related]
36. Classification of BRCA1 missense variants of unknown clinical significance. Phelan CM; Dapic V; Tice B; Favis R; Kwan E; Barany F; Manoukian S; Radice P; van der Luijt RB; van Nesselrooij BP; Chenevix-Trench G; kConFab ; Caldes T; de la Hoya M; Lindquist S; Tavtigian SV; Goldgar D; Borg A; Narod SA; Monteiro AN J Med Genet; 2005 Feb; 42(2):138-46. PubMed ID: 15689452 [TBL] [Abstract][Full Text] [Related]
37. In vitro analysis of genomic instability triggered by BRCA1 missense mutations. Quaresima B; Faniello MC; Baudi F; Crugliano T; Cuda G; Costanzo F; Venuta S Hum Mutat; 2006 Jul; 27(7):715. PubMed ID: 16786532 [TBL] [Abstract][Full Text] [Related]
38. Cancer predisposing missense and protein truncating BARD1 mutations in non-BRCA1 or BRCA2 breast cancer families. De Brakeleer S; De Grève J; Loris R; Janin N; Lissens W; Sermijn E; Teugels E Hum Mutat; 2010 Mar; 31(3):E1175-85. PubMed ID: 20077502 [TBL] [Abstract][Full Text] [Related]
39. Negative feedback loop of BRCA1-BARD1 ubiquitin ligase on estrogen receptor alpha stability and activity antagonized by cancer-associated isoform of BARD1. Dizin E; Irminger-Finger I Int J Biochem Cell Biol; 2010 May; 42(5):693-700. PubMed ID: 20060929 [TBL] [Abstract][Full Text] [Related]
40. Genetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variants. Lovelock PK; Healey S; Au W; Sum EY; Tesoriero A; Wong EM; Hinson S; Brinkworth R; Bekessy A; Diez O; Izatt L; Solomon E; Jenkins M; Renard H; Hopper J; Waring P; Tavtigian SV; Goldgar D; Lindeman GJ; Visvader JE; Couch FJ; Henderson BR; Southey M; Chenevix-Trench G; Spurdle AB; Brown MA; J Med Genet; 2006 Jan; 43(1):74-83. PubMed ID: 15923272 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]